• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

GE Healthcare Unveils First X-Ray AI Algorithm to Assess ETT Placement for COVID-19 Patients

Share:

December 2, 2020

Highlights on this story:
  • GE Healthcare announced a new artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements, a necessary and important step when ventilating critically ill COVID-19 patients.
  • The AI solution is one of five included in GE Healthcare’s Critical Care Suite 2.0, an industry-first collection of AI algorithms embedded on a mobile x-ray device for automated measurements, case prioritization, and quality control.

GE Healthcare today announced a new artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements, a necessary and important step when ventilating critically ill COVID-19 patients. The AI solution is one of five included in GE Healthcare’s Critical Care Suite 2.0, an industry-first collection of AI algorithms embedded on a mobile x-ray device for automated measurements, case prioritization, and quality control. GE Healthcare and UC San Francisco co-developed Critical Care Suite 2.0 using GE Healthcare’s Edison platform, which helps deploy AI algorithms quickly and securely. Critical Care Suite 2.0 is available on the company’s AMX 240 mobile x-ray system.

The on-device AI offers several benefits to radiologists and technologists, including:

– ETT positioning and critical findings: GE Healthcare’s algorithms are a fast and reliable way to ensure AI results are generated within seconds of image acquisition, without any dependency on connectivity or transfer speeds to produce the AI results.

– Eliminating processing delays: Results are then sent to the radiologist while the device sends the original diagnostic image, ensuring no additional processing delay.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Ensuring quality: The AI suite also includes several quality-focused AI algorithms to analyze and flag protocol and field of view errors, as well as auto, rotate the images on-device. By automatically running these quality checks on-device, it integrates them into the technologist’s standard workflow and enables technologist actions – such as rejections or reprocessing – to occur at the patient’s bedside and before the images are sent to PACS.

Impact of ETTs

Up to 45% of ICU patients, including severe COVID-19 cases, receive ETT intubation for ventilation. While proper ETT placement can be difficult, Critical Care Suite 2.0 uses AI to automatically detect ETTs in chest x-ray images and provides an accurate and automated measurement of ETT positioning to clinicians within seconds of image acquisition, right on the monitor of the x-ray system. In 94% of cases, the ET Tube tip-to-Carina distance calculation is accurate to within 1.0 cm. With these measurements, clinicians can determine if the ETT is placed correctly or if additional attention is required for proper placement. The AI-generated measurements – along with an image overlay – are then made accessible in a picture archiving and communication system (PACS).

Improper positioning of the ETT during intubation can lead to various complications, including a pneumothorax, a type of collapsed lung. While the chest x-ray images of a suspected pneumothorax patient are often marked “STAT,” they can sit waiting for up to eight hours for a radiologist’s review. However, when a patient is scanned on a device with Critical Care Suite 2.0, the system automatically analyzes images and sends an alert for cases with a suspected pneumothorax – along with the original chest x-ray – to the radiologist for review via PACS. The technologist also receives a subsequent on-device notification to provide awareness of the prioritized cases.

“Seconds and minutes matter when dealing with a collapsed lung or assessing endotracheal tube positioning in a critically ill patient,” explains Dr. Amit Gupta, Modality Director of Diagnostic Radiography at University Hospital Cleveland Medical Center and Assistant Professor of Radiology at Case Western Reserve University, Cleveland. “In several COVID-19 patient cases, the pneumothorax AI algorithm has proved prophetic – accurately identifying pneumothoraces/barotrauma in intubated COVID-19 patients, flagging them to radiologist and radiology residents, and enabling expedited patient treatment. Altogether, this technology is a game-changer, helping us operate more efficiently as a practice, without compromising diagnostic precision. We soon will evaluate the new ETT placement AI algorithm, which we hope will be equally valuable tool as we continue caring for critically ill COVID-19 patients.”

Research shows that up to 25 percent of patients intubated outside of the operating room have misplaced ETTs on chest x-rays, which can lead to severe complications for patients, including hyperinflation, pneumothorax, cardiac arrest and death. Moreover, as COVID-19 cases climb, with more than 50 million confirmed worldwide, anywhere from 5-15 percent require intensive care surveillance and intubation for ventilatory support.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AMN Healthcare Completes Acquisition of Advanced Medical and Amends Credit FacilityAMN Healthcare Completes Acquisition of Advanced Medical and Amends Credit Facility
  • Garmin Launches New Connected Scale That can Give Users Trends Over TimeGarmin Launches New Connected Scale That can Give Users Trends Over Time
  • CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform CompanyCURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company
  • Conventus Orthopaedics Acquires Novel Intramedullary Technology from IntrafuseConventus Orthopaedics Acquires Novel Intramedullary Technology from Intrafuse
  • Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD ProjectSorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
  • Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle TherapeuticsSio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics
  • Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition CorpVisiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp
  • Pharmaceutical Asset Managements Market Overview with Detailed Analysis, Competitive Landscape, Forecast to 2026|

Trending This Week

  • Scotland’s Life Sciences Strategy Targets £25bn
  • Nectar Lifesciences Shares Surge on Buyback News
  • SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Investment Guide Buy Sell Hold Five Stocks
  • Supriya Lifescience Stock Analysis and Outlook
  • Eiko Lifesciences Financial Performance Analysis 2025

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications